World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
41497
World Ranking
8917
National Ranking
684

Overview

Maggie C.U. Cheang is affiliated with the Institute of Cancer Research in the United Kingdom. Their research predominantly focuses on medicine, with a significant emphasis on biochemistry, genetics, and molecular biology. Within these areas, their subfields of study include oncology, cancer research, pulmonary and respiratory medicine, genetics, and molecular biology.

The primary topics of Maggie C.U. Cheang's work include:

  • Breast Cancer Treatment Studies
  • Cancer Immunotherapy and Biomarkers
  • Estrogen and related hormone effects
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Cancer Genomics and Diagnostics
  • Immunotherapy and Immune Responses

Their publication record shows contributions to several frequent venues, including:

  • UNC Libraries
  • Cancer Research
  • Clinical Cancer Research
  • npj Breast Cancer
  • Journal of Clinical Oncology

Among notable recent papers by Maggie C.U. Cheang are:

  • Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial (2020, The Lancet Oncology)
  • Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer (2020, npj Breast Cancer)
  • Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes (2023, Journal of Clinical Oncology)
  • Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial Profiler (2021, Cancers)
  • Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: The TNT Trial (2021, UNC Libraries)

Frequent co-authors with whom they have collaborated include:

  • Judith M. Bliss
  • Lucy Kilburn
  • Mitch Dowsett
  • Charles M. Perou
  • Holly Tovey

Best Publications

  • Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

    Joel S. Parker;Michael Mullins;Maggie C.U. Cheang;Samuel Leung

  • Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

    Lisa A. Carey;Charles M. Perou;Chad A. Livasy;Lynn G. Dressler

  • Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

    Torsten O. Nielsen;Forrest D. Hsu;Kristin Jensen;Maggie Cheang

  • Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

    Maggie C. U. Cheang;Stephen K Chia;David Voduc;Dongxia Gao

  • Metastatic Behavior of Breast Cancer Subtypes

    Hagen Kennecke;Rinat Yerushalmi;Ryan Woods;Maggie Chon U. Cheang

  • Breast Cancer Subtypes and the Risk of Local and Regional Relapse

    K. David Voduc;Maggie C.U. Cheang;Scott Tyldesley;Karen Gelmon

  • Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.

    Maggie C.U. Cheang;David Voduc;Chris Bajdik;Samuel Leung

  • Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

    Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks

  • Mutation Tracking in Circulating Tumor DNA Predicts Relapse in Early Breast Cancer

    Isaac Garcia-Murillas;Gaia Schiavon;Gaia Schiavon;Britta Weigelt;Charlotte Ng

  • A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer

    Torsten O Nielsen;Joel S Parker;Samuel Leung;K David Voduc

  • Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: The TNT Trial

    Andrew Tutt;Andrew Tutt;Holly Tovey;Maggie Chon U Cheang;Sarah Kernaghan

  • Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

    Aleix Prat;Maggie Chon U. Cheang;Miguel Martín;Joel S. Parker

  • Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer

    Aleix Prat;Barbara Adamo;Maggie C.U. Cheang;Carey K. Anders

  • Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

    Judith Hugh;John Hanson;Maggie Chon U. Cheang;Torsten O. Nielsen

  • Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

    Marc Tischkowitz;Marc Tischkowitz;Jean-Sébastien Brunet;Jean-Sébastien Brunet;Louis R. Bégin;David G. Huntsman

  • Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib

    Lisa A. Carey;Donald A. Berry;Constance T. Cirrincione;William T. Barry

  • Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers.

    Stephen Chia;Brian Norris;Caroline Speers;Maggie Cheang

  • Chemotherapy response and recurrence-free survival in Neoadjuvant breast cancer depends on biomarker profiles: Results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

    Laura J. Esserman;Donald A. Berry;Maggie C. U. Cheang;Christina Yau

  • Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells

    Brent W Sutherland;Jill Kucab;Joyce Wu;Cathy Lee

  • Nuclear beta-catenin in mesenchymal tumors.

    Tony L Ng;Allen M Gown;Todd S Barry;Maggie C U Cheang

Frequent Co-Authors

Torsten O. Nielsen
Torsten O. Nielsen University of British Columbia
Charles M. Perou
Charles M. Perou University of North Carolina at Chapel Hill
Mitch Dowsett
Mitch Dowsett Breast Cancer Research Foundation
David G. Huntsman
David G. Huntsman University of British Columbia
Andrew Tutt
Andrew Tutt Institute of Cancer Research
Karen A. Gelmon
Karen A. Gelmon University of British Columbia
Judith M. Bliss
Judith M. Bliss Institute of Cancer Research
Aleix Prat
Aleix Prat University of Barcelona
Matthew J. Ellis
Matthew J. Ellis Baylor College of Medicine
Joel S. Parker
Joel S. Parker University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in Biology and Biochemistry often leads to diverse opportunities, both inside and outside the lab. Many students choose interdisciplinary paths that build on their biology background, such as clinical research, public health, or healthcare administration. Today, online degrees offer the flexibility to expand your qualifications from anywhere in the world.

For those interested in combining patient care with a strong science foundation, an asn program online can be a great option. Aspiring nutritionists and health advocates may want to consider an online bachelor's in nutrition to blend biology with real-world health practices.

If you see yourself in healthcare leadership, the number of cahme accredited mha programs available online is growing, providing pathways into healthcare management without needing to relocate. For those seeking advanced nursing roles, a dnp online no clinicals option can help you attain a doctorate while balancing work and study.

Whether you're starting out or aiming for the next step, these online degrees can help shape a fulfilling career inspired by biology and biochemistry.

Best Scientists Citing Maggie C.U. Cheang

Trending Scientists

Recently Published Articles